Nephros, Inc. Share Price

Equities

NEPH

US6406714005

Environmental Services & Equipment

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
2.19 USD 0.00% Intraday chart for Nephros, Inc. +4.29% -36.71%
Sales 2024 * 16.7M 1.39B Sales 2025 * 18.79M 1.57B Capitalization 23.09M 1.93B
Net income 2024 * - 0 Net income 2025 * - 0 EV / Sales 2024 * 1.38 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.23 x
P/E ratio 2024 *
-33.7 x
P/E ratio 2025 *
219 x
Employees 31
Yield 2024 *
-
Yield 2025 *
-
Free-Float 87.77%
More Fundamentals * Assessed data
Dynamic Chart
1 week+4.29%
1 month-3.52%
3 months-38.83%
6 months+36.02%
Current year-36.71%
More quotes
1 week
2.06
Extreme 2.06
2.31
1 month
1.97
Extreme 1.97
2.32
Current year
1.97
Extreme 1.97
4.00
1 year
1.13
Extreme 1.13
4.04
3 years
0.91
Extreme 0.9051
11.67
5 years
0.00
Extreme 0
11.67
10 years
0.00
Extreme 0
11.67
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 31/23/31
Director of Finance/CFO 59 01/11
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 67 19/07/19
Director/Board Member 52 10/18/10
Director/Board Member 53 08/19/08
More insiders
Date Price Change Volume
26/24/26 2.19 0.00% 4,904
24/24/24 2.19 +2.34% 7,314
23/24/23 2.14 +2.39% 1,242
22/24/22 2.09 -0.48% 26,048
19/24/19 2.1 +3.45% 9,212

Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST

More quotes
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. It operates through the Water Filtration segment. In the medical markets, it sells water filtration products. In the commercial markets, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Its products are marketed primarily to the food service, hospitality, convenience store, and health care markets. These commercial products are also marketed into medical markets, as supplemental filtration to its medical filters. The Company’s filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.19 USD
Average target price
4.75 USD
Spread / Average Target
+116.89%
Consensus